Document is current
Any future updates will be listed below
-
Authors
Liu, Enze
Becker, Nathan
Sudha, Parvathi
Dong, Chuanpeng
Liu, Yunlong
Keats, Jonathan https://orcid.org/0000-0003-4375-7399
Morgan, Gareth
Walker, Brian A. https://orcid.org/0000-0002-8615-6254
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA249981, R01CA249981)
Leukemia and Lymphoma Society (6602-20, 6602-20)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Leukemia and Lymphoma Society
- License Information
-
More Information
Article History
Received: 12 August 2022
Revised: 27 December 2022
Accepted: 5 January 2023
First Online: 20 January 2023
Competing interests
: BAW received unrelated research support from Bristol-Myers Squibb and Genentech and has received consulting fees from Genentech and Sanofi. GJM has unpaid advisory positions for Bristol Myers Squibb, Sanofi, Karyopharm, Janssen, GlaxoSmithKline, Amgen, Oncopeptides, and AbbVie.
